Michael R Grever, MD

Michael Grever

College

College of Medicine

Department/Division

Internal Medicine

Academic Title

Chair

Research Program

Leukemia Research

Research Interest

Leukemia, Lymphocytic, Chronic, B-Cell, Cancer, Leukemia, Myeloid, Acute, Leukemia, Leukemia, Hairy Cell, Melanoma, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Tumor Lysis Syndrome, Neutropenia, Lymphoma, Mantle-Cell

Dr. Grever has over 30 years of experience in experimental chemotherapy and drug development for patients with chronic lymphocytic leukemia (CLL) and other hematologic malignancies. He performed the initial phase I studies on purine nucleoside analogs in patients with hematologic malignancies and conducted one of the initial phase II studies of fludarabine in patients with CLL. Together with John C. Byrd, MD, Dr. Grever was among the first to investigate the potential of histone deacetylase inhibitors (depsipeptide) and cyclin-dependent kinase inhibitors (flavopiridol) in CLL; he oversaw both laboratory and phase I clinical studies of both these agents.


Education and Background

Education

  • MD, University of Pittsburgh

    Pittsburgh, PA (USA)

Residencies

  • Internal Medicine Internship

    Presbyterian University Hospital, University of Pittsburgh

    Pittsburgh, PA (USA)

  • Internal Medicine Residency

    Presbyterian University Hospital, University of Pittsburgh

    Pittsburgh, PA (USA)

Fellowship

  • Hematology and Oncology Fellowship

    The Ohio State University College of Medicine

    Columbus, OH (USA)

Office Location

Room 392 Twelfth Avenue, 395 West

395 W 12th Avenue, Columbus, Ohio 43210


614-293-8724

614-293-6656



Publications

Back to Researcher Search

Please enter a keyword (i.e. Name, Research Interest) or choose a Research Program

OR

Please enter a keyword (i.e. Name, Cancer Type) or choose a Principle Investigator

OR

Search for Clinical Trials

Find a Scientific Publication